
Sustaining and Spreading the Contrast Reducing Injuries Sustained by Kidneys (Contrast RISK) Initiative Across Alberta’s Cardiac Catheterization Centres
Nephrology & Urology (Kidneys & Urinary)
2024-11-30 – Present
The Contrast RISK project, led by Drs. Matthew James and Michelle Graham, with Dr. Bryan Har serving as the Foothills Medical Centre site champion, and Dr. Kelly Burak, Assistant Dean, PLP
relaunched in 2024 under a Health Innovation Implementation and Spread (HIIS) grant, is a provincial initiative aimed at reducing contrast-induced acute kidney injury (AKI) in patients undergoing cardiac catheterization. AKI remains a common and preventable complication associated with increased morbidity, mortality, and healthcare costs. Building on the success of the original PRIHS project (2018–2019), which demonstrated that facilitated audit and feedback can reduce AKI rates, this initiative focuses on re-engaging interventional cardiologists in evidence-based practices, including appropriate contrast use, hydration, and follow-up care. The project integrates clinical decision support, education, and facilitated audit and feedback to drive sustainable practice change across Alberta’s three catheterization laboratories. The original implementation demonstrated a reduction in AKI incidence from 8.6% to 7.2%, reinforcing the impact of A&F in improving patient outcomes.
During this reporting period, the project achieved key milestones to support implementation readiness and clinician engagement. PLP supported ethics approval and site engagement across all three catheterization laboratories (Foothills Medical Centre, Mazankowski Alberta Heart Institute, and CK Hui Heart Centre), alongside the onboarding of site champions and establishment of an advisory committee.
Significant progress was made in data validation and workflow alignment, with close collaboration between analysts and clinicians to ensure accuracy and completeness of AKI risk metrics and reporting. PLP also facilitated process improvement discussions with cath lab teams, focusing on integrating AKI risk scoring, contrast limits, and hydration practices into routine workflows and improving team communication across pre-, intra-, and post-procedural phases.
PLP delivered three A&F sessions with interventional cardiologists and incorporated a Commitment-to-Change (CTC) approach to support reflection and intended practice change. While early engagement varied across sites, this was addressed through ongoing follow-up, strengthened site champion involvement, and tailored engagement strategies to support sustained participation.
Key Performance Indicators and Early Indicators of Impact includes:
3 catheterization sites engaged provincially
Site champions onboarded across all sites
3 A&F sessions delivered
Commitment-to-Change approach implemented
Next steps include formal project evaluation in collaboration with the PLP data analytics team and delivery of additional A&F sessions in Spring 2026 to support continued engagement and practice change.
“The Physician Learning Program (PLP) has played a key role in supporting the Contrast RISK initiative. Through their expertise in audit and feedback and implementation, PLP has enabled the translation of data into meaningful insights for clinicians. This approach has fostered strong physician engagement, supported reflection on current practice, and helped teams identify practical, site-specific opportunities for process improvement.”
Supporting interventional cardiologists with personalized data and feedback to reduce contrast-induced kidney injury and improve patient safety across Alberta’s cardiac catheterization centres.